SYNAZE 137mcg / 50mcg / dose nasal spray, suspension medication leaflet

R01AD58 azelastine + fluticasone • Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids

Azelastine+fluticasone is a combination medication used in the treatment of seasonal and perennial allergic rhinitis. Azelastine is an antihistamine that blocks H1 histamine receptors, reducing allergic symptoms such as sneezing and itching, while fluticasone is a corticosteroid that reduces inflammation and nasal congestion.

This combination is available as a nasal spray and is administered locally, usually once or twice daily, depending on the severity of symptoms. It is indicated for patients who require both rapid symptom relief and long-term control of allergic inflammation.

Common side effects include nasal irritation, bitter taste, nasal dryness, and occasionally nosebleeds. In rare cases, severe adverse reactions such as nasal fungal infections or allergic reactions may occur. It is important for patients to follow usage instructions and avoid overuse.

Azelastine+fluticasone is an effective therapeutic option for managing allergic rhinitis, providing both rapid relief and long-term symptom control.

General data about SYNAZE 137mcg / 50mcg / dose

Substance: azelastine + fluticasone

Date of last drug list: 01-05-2022

Commercial code: W68723001

Concentration: 137mcg / 50mcg / dose

Pharmaceutical form: nasal spray, suspension

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MEDA PHARMA GMBH & CO. KG - GERMANIA

Holder: VIATRIS HEALTHCARE LIMITED - IRLANDA

Number: 11004/2018/01

Shelf life: 18 months-after packing for marketing; after the first opening-6 months

Pharmaceutical forms available for azelastine + fluticasone